Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1999-01-12
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 14, 530326, 530327, A61K 3800
Patent
active
058589805
ABSTRACT:
Peptides ate provided that are related to immunodominant regions of human MBP.
REFERENCES:
patent: 4634590 (1987-01-01), Cohen et al.
patent: 5130297 (1992-07-01), Sharma et al.
patent: 5260422 (1993-11-01), Clark et al.
patent: 5284935 (1994-02-01), Clark et al.
patent: 5468481 (1995-11-01), Sharma et al.
Vandenbark et al., "Determinants of Human Myelin Basic Protein that Induce Encephalitogenic T Cells in Lewis Rats." J. of Immunol., 143: 3512, 1989.
Martin et al., "Fine Specifity and HLA Restriction of Myelin Basic Protein . . . " J. of Immunol., 145, 540-548 No. 2, Jul. 15, 1990.
deFerra et al., "Alternative Splicing Accounts for the Four Forms of Myelin Basic Protein." Cell, 43: 721-727, Dec. 1985.
Margalit et al., "Prediction of Immunodominant Helper T-cell Antigenic Sites from the Primary Sequence", J. of Immunol., 138:: 2213, 1987.
Adorini et al., Nature 342:800-2, 1989.
Allegretta, M., et al., Science, 247:718-721, 1990.
Avrilionis, K. and Boggs, J.M., J. Neuroimmunol. 35:201-10, 1991.
Ben-Nun, A., et al., J. Immunol., 129:303-308, 1982.
Blackman et al., Science 248:1335-41, 1990.
Burns, F.R., et al., J. Exp. Med., 169:27-39, 1989.
Buss et al., Cell 47:1071-77, 1988.
Cresswell, Nature 343:593-94, 1990.
DeFreitas et al., Proc. Natl. Acad. Sci. USA 83:2637-41, 1986.
Gaur et al., Science 258:1491-4, 1992.
Germain, Nature 344:19-22, 1990.
Guillet et al., Nature 324:260-62, 1986.
Guillet et al., Science 235:865-70, 1987.
Hodes et al., Science 246:1041-44, 1989.
Howell, M.D., et al., Science, 246:668-670, 1989.
Janeway, Nature 341:482-83, 1989.
Kaye et al., Nature 341:746-49, 1989.
Lider et al., Ann. N. Y. Acad. Sci., pp. 267-273, 1986.
MacDonald, Science 246:982, 1989.
Martin, R., et al., J. Immunol. 145:540-8, 1990.
Martin, R., et al., J. of Exper. Med. 173:19-24, 1991.
Martin, R., et al., J. Immunol. 148:1359-1366, 1992.
Mokhtarian, F., et al., Nature, 309:356-358, 1984.
Nikolic-Zugic et al., Nature 344:65-67, 1990.
Ogasawara et al., Nature 325:450-52, 1987.
Oksenberg et al., Nature 345:344-46, 1990.
Ota, K, et al., Nature, 346:183-7, 1990.
Pette, M., et al., Proc. Natl. Acad. Sci., USA 87:7968-72, 1990.
Schwartz, Ann. Rev. Immunol. 3:237-61, 1985.
Su, X., et al., J. Neuroimmunol. 34:181-190, 1991.
Vandenbark, A.A., et al., Nature, 341:541-433, 1989.
Weiner et at., (Abstr) Neurology (Suppl. 1) 39:172, 1989.
Wucherpfenning, K.W. et al., Science 248:1016-9, 1990.
Zambil, S. S., et al., Nature, 324:258-260, 1986.
International Search Report.
Higgins et al., J. Immunology, 140:440-445, 1988.
Eylar, Adv. Exp. Med. Bio., 98:259-281, 1978.
Sriram et al., Cell. Immunol., 75:378-382, 1983.
Nagler-Anderson et al., PNAS, 83:7443-7446, 1986.
Schoen, J. Immunol., 128:717-719, 1982.
Higgins et al., Annals Neurology, abstract No. P154, 1986.
Whitacre et al., 6th Int'l. Cong. Immunol., abstract No. 3.62.21, 1986.
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol., 134:2328-2332, 1985.
Fritz et al., J. Immunol., 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitake et al., J. Bio. Chem, 250:9106-9111, 1975.
Thompson et al., Clin. Exp. Immunol., 64:581-586, 1985.
Lider et al., J. Immunol., 142:748-752, 1989.
Friedman et al., PNAS, 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity, 1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Bitar et al., Cell. Immunol., 112:364-370, 1988.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Mowat, Immunol. Today, 8:93-98, 1987.
Weiner et al., Science, 259:1321-1324, 1993.
Campbell et al, Arch. Neurol., 29:10-15, 1973.
Carnegie et al., Immunol. 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.
Martenson, Journal of Neurochemistry, vol. 40, No. 4, pp. 951-968, 1983.
Richert et al., Annals New York Academy of Sciences, vol. 540, pp. 345-348, 1988.
Richert et al., Annals of Neurology, vol. 26, No. 3, pp. 342-346, Sep. 1989.
Fujinami et al., Science, vol. 230, pp. 1043-1045, Nov. 29, 1985.
Uyemura et al., Journal of Neurochemistry, vol. 39, No. 3, pp. 895-898, 1982.
Hruby et al., Journal of Neurochemistry, vol. 44, No. 2, pp. 637-650, 1985.
Jahnke et al., Science, vol. 229, pp. 282-284, Jul. 19, 1985.
Driscoll et al., The Journal of Immunology, vol. 117, No. 1, pp. 110-114, Jul. 1976.
Swanborg, The Journal of Immunology, vol. 114, No. 1, Part 1, pp. 191-194, Jan. 1975.
Higgins et al., The Journal of Immunology, vol. 140, No. 2, pp. 440-445, 1988.
J.G. Michael, Immunological Investigations, vol. 18 (9&10), pp. 1049-1054, 1989.
Al-Sabbagh Ahmad
Hafler David A.
Miller Ariel
Weiner Howard L.
AutoImmune Inc.
Delacroix-Muirheid C.
Tsang Cecilia J.
LandOfFree
Peptide fragments of myelin basic protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide fragments of myelin basic protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide fragments of myelin basic protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516057